| Cellulose acetate electrospun nanofibers for drug delivery systems: Applications and recent advances K Khoshnevisan, H Maleki, H Samadian, S Shahsavari, MH Sarrafzadeh, ... Carbohydrate polymers 198, 131-141, 2018 | 332 | 2018 |
| Masculinization of genetic female Nile tilapia (Oreochromis niloticus) by dietary administration of an aromatase inhibitor during sexual differentiation JY Kwon, V Haghpanah, LM Kogson‐Hurtado, BJ McAndrew, DJ Penman Journal of Experimental Zoology 287 (1), 46-53, 2000 | 239 | 2000 |
| Shift working and risk of lipid disorders: a cross-sectional study M Ghiasvand, R Heshmat, R Golpira, V Haghpanah, A Soleimani, ... Lipids in health and disease 5, 1-5, 2006 | 172 | 2006 |
| Efficacy of the hatching event in assessing the embryo toxicity of the nano-sized TiO2 particles in zebrafish: A comparison between two different classes of hatching-derived … SM Samaee, S Rabbani, B Jovanović, MR Mohajeri-Tehrani, ... Ecotoxicology and Environmental Safety 116, 121-128, 2015 | 99 | 2015 |
| Cardiac malformations in fetuses of gestational and pre gestational diabetic mothers A Tabib, N Shirzad, S Sheikhbahaei, S Mohammadi, M Qorbani, ... Iranian journal of pediatrics 23 (6), 664, 2013 | 71 | 2013 |
| Immunohistochemical study of oestrogen receptors in 351 human thyroid glands. SM Tavangar, M Monajemzadeh, B Larijani, V Haghpanah Singapore medical journal 48 (8), 744-747, 2007 | 71 | 2007 |
| Qualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARβ2 genes in papillary thyroid carcinoma J Mohammadi-asl, B Larijani, Z Khorgami, SM Tavangar, V Haghpanah, ... Medical oncology 28, 1123-1128, 2011 | 69 | 2011 |
| Endocrine cancer in Iran: based on cancer registry system V Haghpanah, B Soliemanpour, R Heshmat, AR Mosavi-Jarrahi, ... Indian journal of cancer 43 (2), 80-85, 2006 | 68 | 2006 |
| Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer V Haghpanah, P Fallah, R Tavakoli, M Naderi, H Samimi, M Soleimani, ... Tumor Biology 37, 1299-1308, 2016 | 65 | 2016 |
| Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment B Fallahi, K Adabi, M Majidi, A Fard-Esfahani, R Heshmat, B Larijani, ... Clinical nuclear medicine 36 (4), 277-282, 2011 | 65 | 2011 |
| Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma SM Tavangar, A Shojaee, HM Tabriz, V Haghpanah, B Larijani, ... Pathology-Research and Practice 206 (5), 305-309, 2010 | 64 | 2010 |
| Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017 S Azadnajafabad, S Saeedi Moghaddam, E Mohammadi, N Rezaei, ... Cancer medicine 10 (7), 2496-2508, 2021 | 58 | 2021 |
| Epidemiologic analysis of the Tehran cancer institute data system registry (TCIDSR) B Larijani, M Shirzad, MA Mohagheghi, V Haghpanah, AR Mosavi-Jarrahi, ... Asian Pac J Cancer Prev 5 (1), 36-9, 2004 | 58 | 2004 |
| Survivin gene polymorphism association with papillary thyroid carcinoma N Yazdani, FA Sayahpour, V Haghpanah, P Amiri, M Shahrabi-Farahani, ... Pathology-Research and Practice 208 (2), 100-103, 2012 | 57 | 2012 |
| Primary thyroid malignancies in Tehran, Iran B Larijani, MA Mohagheghi, MH Bastanhagh, AR Mosavi-Jarrahi, ... Medical principles and practice 14 (6), 396-400, 2005 | 52 | 2005 |
| Immunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinoma V Haghpanah, P Shooshtarizadeh, R Heshmat, B Larijani, SM Tavangar Applied Immunohistochemistry & Molecular Morphology 14 (4), 422-425, 2006 | 44 | 2006 |
| Expression of matrix metalloproteinase-2, but not caspase-3, facilitates distinction between benign and malignant thyroid follicular neoplasms S Sanii, H Saffar, HM Tabriz, M Qorbani, V Haghpanah, SM Tavangar Asian Pacific journal of cancer prevention 13 (5), 2175-2178, 2012 | 42 | 2012 |
| Expression of galectin-3, nm-23, and cyclooxygenase-2 could potentially discriminate between benign and malignant pheochromocytoma H Saffar, S Sanii, R Heshmat, V Haghpanah, B Larijani, A Rajabiani, ... American journal of clinical pathology 135 (3), 454-460, 2011 | 39 | 2011 |
| Expression of EGFRvIII in thyroid carcinoma: immunohistochemical study by camel antibodies K Omidfar, Z Moinfar, AN Sohi, SM Tavangar, V Haghpanah, R Heshmat, ... Immunological investigations 38 (2), 165-180, 2009 | 38 | 2009 |
| HLA‐DR association in papillary thyroid carcinoma MM Amoli, N Yazdani, P Amiri, F Sayahzadeh, V Haghpanah, ... Disease markers 28 (1), 49-53, 2010 | 35 | 2010 |
Bagher Larijani, MDProfessor of Medicine/Endocrinology Division Chief, Head of EMRI, Tehran University (TUMS)Email được xác minh tại tums.ac.ir